DNLI

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Denali Therapeutics (DNLI) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DNLI is expected to report earnings to fall 3.37% to -60 cents per share on March 03

Denali Therapeutics DNLI Stock Earnings Reports

Q4'24

Est.

$-0.61

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.02

Q4'23

Missed

by $0.06

The last earnings report on November 06 showed earnings per share of -62 cents, missing the estimate of -59 cents. With 831.30K shares outstanding, the current market capitalization sits at 4.09B.

View a ticker or compare two or three

Compare

DNLI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DNLI
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DNLI (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

161 Oyster Point Boulevard

Phone

+1 650 866-8548

Employees

445

Web

https://www.denalitherapeutics.com